GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent Health Corp (OTCPK:EMGE) » Definitions » Loans Receivable

Switch to:

Emergent Health (Emergent Health) Loans Receivable : $0.00 Mil (As of . 20)

View and export this data going back to 2007. Start your Free Trial

What is Emergent Health Loans Receivable?

Emergent Health's Loans Receivable for the quarter that ended in . 20 was $0.00 Mil.

Emergent Health Loans Receivable Historical Data

The historical data trend for Emergent Health's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent Health Loans Receivable Chart

Emergent Health Annual Data

Trend

Loans Receivable

Emergent Health Quarterly Data

Loans Receivable

Emergent Health Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Emergent Health Loans Receivable Related Terms

Thank you for viewing the detailed overview of Emergent Health's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Emergent Health (Emergent Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent Health Corp (OTCPK:EMGE) » Definitions » Loans Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

519 8th Avenue, 25th Floor, New York, NY, USA, 10018

Website

https://www.emergenthealthcompany.com

Emergent Health Corp manufactures and sells vitamin products to retail customers across the United States of America.

Emergent Health (Emergent Health) Headlines

From GuruFocus

Emergent Projects $3.5 Million in Revenues With Acquisition of Nanosthetic Corp. Fueling Evolutionary Biologics

By ACCESSWIRE ACCESSWIRE • 02-07-2023

Emergent Acquires Regen Biowellness, Inc.

By ACCESSWIRE ACCESSWIRE • 08-02-2022

Emergent Executes Letter of Intent To Acquire Evolutionary Biologics; Former L'Or�al President Jim Morrison To Become Full Time CEO of Emergent

By ACCESSWIRE ACCESSWIRE • 07-19-2022

Emergent Executes Letter of Intent to Partner with Lumina to Commence its "Content Based Marketing" Initiative Through Influencers

By ACCESSWIRE ACCESSWIRE • 11-23-2022

Emergent Announces "The Wholistic Company" - Naturally Inspired Products

By ACCESSWIRE ACCESSWIRE • 12-01-2022

Emergent Executes Joint Venture Agreement with Nutralife Biosciences and Provides PharmaZu Corporate Update

By ACCESSWIRE ACCESSWIRE • 07-08-2022

Emergent Announces Letter of Intent to Partner with Clicktivated, the First and Only Fully Clickable Livestream Video to Create "Shoppable Content," Entering the $20 Billion Live Streaming E-Commerce Marketplace

By ACCESSWIRE ACCESSWIRE • 12-13-2022

Emergent Acquires Evolutionary Biologics, Former L'Or�al President Jim Morrison to Become Full Time CEO of Emergent Effective August 15, 2022

By ACCESSWIRE ACCESSWIRE • 08-09-2022

Emergent Intends to Become a Fully Reporting SEC Issuer and List its Shares on the OTCQB

By ACCESSWIRE ACCESSWIRE • 01-10-2023

(EMGE) Emergent Health Enters Acquisition Talks with Revenue-Producing Medical Company

By ACCESSWIRE ACCESSWIRE • 02-17-2023

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.